Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
AC Immune (ACIU) had Return on Investments of -33.89% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.45M |
|
$-18.36M |
|
-- |
|
$0.45M |
|
$18.87M |
|
$-18.42M |
|
$0.06M |
|
$-18.36M |
|
$-18.36M |
|
$-18.36M |
|
$-18.36M |
|
$-18.36M |
|
$-18.36M |
|
$-18.42M |
|
$-17.71M |
|
100.75M |
|
100.75M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$116.74M |
|
$2.40M |
|
$69.44M |
|
$186.18M |
|
$114.29M |
|
-- |
|
$17.71M |
|
$132.01M |
|
$54.17M |
|
$-6.68M |
|
$54.17M |
|
101.74M |
|
| Cash Flow Statement Financials | |
$-83.60M |
|
$76.70M |
|
$-1.23M |
|
$43.78M |
|
$32.34M |
|
$-11.44M |
|
$5.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4048.63% |
|
-4048.63% |
|
-- |
|
-4036.25% |
|
-4036.25% |
|
$-84.67M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.39 |
|
233.54 |
|
-33.89% |
|
275.00% |
|
-9.86% |
|
|
Return on Investments |
-33.89% |
$0.53 |
|
$-0.84 |
|
$-0.83 |
|